In Q4 of 2021, WBR Insights surveyed 100 Directors of Supply Chain Management and similar from pharma organizations across Europe and North America to find out about the challenges they face in 2021 and the innovative solutions they are putting in place.

We’re pleased to announce that we’re attending LogiPharma 2022, the world’s leading Pharma Supply event, from April 05th to April 07th, in Nice, France.

We believe automation is essential to making supply chains more visible and removing inefficiencies that come with manual tasks. Watch our webinar to find out more about how to achieve automation in your clinical supply chain.

TSS introduces a new era of efficiency, with next-generation Bluetooth Low Energy temperature monitoring solutions that help life science supply chain professionals automate their processes for time and cost savings while securing patient safety.

Get introduced to the solution tailored to GxP critical shipments – BLE technology for temperature monitoring

While cloud-based solutions have seen high implementation levels into specific portions of the supply chain in the pharma and life science industry, others have been neglected. Of course, one of the clear benefits of cloud-based temperature monitoring solutions for your data is cost-savings, but there are other tangible benefits for pharma companies that utilize cloud solutions to storage their temperature data.

Customer onboarding is one of the most important steps in making sure your customers are happy and confident in using your product. At TSS, we help companies in life sciences monitor complex temperature budgets with our advanced automated cloud software and temperature loggers. Making the onboarding process smooth is key to long-term customer satisfaction.

TSS, a leading provider of temperature-monitoring solutions for the life-science industry, proudly announces that it has retained the EcoVadis Silver Medal for the second consecutive year. This recognition is a testament to TSS’s ongoing commitment to sustainability, even as EcoVadis raised the bar for its assessment criteria in 2024.

Pharmaceutical companies are under pressure to bring new drugs to market quickly. This urgency is driven by the needs of patients, requirements from authorities, and investors. Clinical trials are a crucial part of this process, but they can be delayed by manual processes.

In the complex world of pharmaceuticals, sustainability is becoming a key part of business strategy. The push for a greener future is driven not only by government rules but also by the expectations of communities and customers. However, making the supply chain sustainable while balancing costs and maintaining high quality can be challenging. This requires careful planning and a commitment to long-term goals.

In the life-science industry, finding the right balance between cost and quality in the supply chain is crucial. This balance ensures that pharma companies remain financially healthy while delivering safe and effective products to patients. However, achieving this balance can be challenging due to the complexities of quality management, procurement, and temperature control.

World Telecommunication & Information Society Day (WTISD), celebrated annually on May 17th, highlights the pivotal role of digital technologies in fostering societal progress. This day serves as a reminder of the transformative power of innovation and digitalisation in building a sustainable future. At TSS, we are dedicated to leveraging advanced technologies to enhance the pharmaceutical supply chain while promoting sustainability.

Pharmaceutical companies are under pressure to bring new drugs to market quickly. This urgency is driven by the needs of patients, requirements from authorities, and investors. Clinical trials are a crucial part of this process, but they can be delayed by manual processes.

In the pharmaceutical industry, maintaining precise temperature control is paramount to ensuring product quality and compliance with regulatory standards. The integrity of pharmaceutical products is heavily reliant on storage conditions, with deviations in temperature potentially compromising their efficacy and safety.

Are you in pursuit of optimizing the temperature management of your clinical trials supply chain? Get inspired by experts from the field, and learn from their experiences.

The TSS User Forum is a platform for thought leadership and innovation in supply chain and temperature control technologies. This forum gathered industry experts from some of the most respected life science companies worldwide, covering topical realities such as automation benefits, data management, supply chain sustainability, and Direct-To-Patient.

Where do the majority of your temperature excursions occur? Why not eliminate them?

In an era where people can make instant cash transfers electronically from their phone and order physical goods to be delivered in hours to their location, there is a portion of the Clinical Supply Chain that seems mired in a staff intensive, manual, reactive business process. That process is evaluating temperature excursions for Clinical Trial material.

Temperature management is critical when it comes to ensuring patient safety in clinical development, but we continue to use legacy point solutions that require heavy manual processes and duplication of data.

Supply chain digitalization, or rather digital transformation, provides a path to sustainable solutions for many of the challenges in managing the pharmaceutical industry’s supply chain such as compliance, traceability, end-to-end visibility, error-reduction, quality assurance and process efficiencies.

Digital temperature monitoring along every step of the pharmaceutical supply chain is quickly becoming the new norm. Government guidelines like the EU’s Good Distribution Practices (GDP) and the guidelines of UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) have seen to increased uptake of digital temperature monitoring across the Europe’s pharmaceutical industry.

Learn how one of the world’s largest pharma organisations saves millions of dollars and thousands of tonnes of CO2 with a clean, simple, and efficient supply chain.

When TSS received the request to support Sandoz, the Novartis generics and biosimilar division, from its client Novartis, a multinational pharmaceutical company based in Switzerland, citing their need for urgent support with surveillance of critical shipments related to a COVID-19, the obvious solution was TSS Real-Time Monitoring solution.

For companies in the pharmaceutical and life sciences industry, GxP data is a critical element of supply chain best practices. Indeed, there is hardly any requirement, from visibility to synchronized logistics, which does not rely on accessing the right data.

The Future of Temperature Monitoring: How to lower the CO2 footprint with a Circular Supply Solution

Are you in pursuit of optimizing the temperature management of your clinical trials supply chain? Get inspired by experts from the field, and learn from their experiences.

Where do the majority of your temperature excursions occur? Why not eliminate them?

In light of the recent EMA and FDA guidelines, this session will discuss what role temperature monitoring may play in decentralized (DCT) and direct-to-patient (DTP) studies.

Where do the majority of your temperature excursions occur? Why not eliminate them?

We are excited to join the 20th Anniversary edition of Clinical Trial Supply East Coast on the 19th and 20th October 2022 in the Sheraton King of Prussia. The conference covers all things CTS from reducing timelines and streamlining processes to handling clinical supplies in a decentralized trial world. Along speakers from Pfizer, Merck, Janssen and many more we will present how digitalization of temperature processes can improve business outcomes in clinical trials.

New technologies for tracking and temperature logging hold great potential, but which to choose? Get a copy of our latest white paper.

Temperature management is critical when it comes to ensuring patient safety in clinical development, but we continue to use legacy point solutions that require heavy manual processes and duplication of data.